Schnitzler Syndrome Disease Treatment Market: How Is IL-1 Blockade...

agregó una foto Health

2026-07-28 09:52:37 -

Schnitzler Syndrome Disease Treatment Market: How Is IL-1 Blockade Transforming Outcomes for This Rare Autoinflammatory Disorder?

Schnitzler syndrome — the late-onset autoinflammatory disease characterized by chronic urticarial rash, monoclonal IgM gammopathy, intermittent fever, bone pain, and elevated inflammatory markers — remained a diagnostic enigma and therapeutic challenge for decades until the discovery of interleukin-1β as the central pathogenic cytokine, with the Schnitzler Syndrome Disease...

0 Commentarios 0 Acciones 534 Views 0 Vista previa